Related Experiment Video
Updated: Jun 26, 2026
Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025
Matrix metalloproteinase activity in pediatric acute lung injury
Michele Y F Kong1, Amit Gaggar, Yao Li
1Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL 35233, USA. mkong@peds.uab.edu
Abstract:
Pediatric Acute Lung Injury (ALI) is associated with a high mortality and morbidity, and dysregulation of matrix metalloproteinases (MMPs) may play an important role in the pathogenesis and evolution of ALI. Here we examined MMP expression and activity in pediatric ALI compared with controls. MMP-8, -9, and to a lesser extent, MMP-2, -3, -11 and -12 were identified at higher levels in lung secretions of pediatric ALI patients compared with controls. Tissue Inhibitor of Matrix metalloproteinase-1 (TIMP-1), a natural inhibitor of MMPs was detected in most ALI samples, but MMP-9:TIMP-1 ratios were high relative to controls. In subjects who remained intubated for >or=10 days, MMP-9 activity decreased, with > 80% found in the latent form. In contrast, almost all MMP-8 detected at later disease course was constitutively active. Discriminating MMP-9:TIMP-1 ratios were found in those who had a prolonged ALI course. These results identify a specific repertoire of MMP isoforms in the lung secretions of pediatric ALI patients, and demonstrate inverse changes in MMPs -8 and -9 with protracted disease.
Insights
Matrix metalloproteinases (MMPs) are elevated in pediatric Acute Lung Injury (ALI). Specific MMP patterns, particularly MMP-9 to TIMP-1 ratios, correlate with prolonged ALI duration and disease severity.
Area of Science:
- Pulmonary Medicine
- Biochemistry
- Pediatric Critical Care
Background:
- Pediatric Acute Lung Injury (ALI) presents significant mortality and morbidity risks.
- Dysregulation of matrix metalloproteinases (MMPs) is implicated in ALI pathogenesis and progression.
Purpose of the Study:
- To investigate the expression and activity of MMPs in pediatric ALI.
- To compare MMP profiles in ALI patients versus control subjects.
- To explore the relationship between MMPs and ALI disease course.
Main Methods:
- Analysis of lung secretions from pediatric ALI patients and controls.
- Quantification of MMP-8, MMP-9, and Tissue Inhibitor of Matrix metalloproteinase-1 (TIMP-1) levels.
- Assessment of MMP activity and MMP-9:TIMP-1 ratios.
Main Results:
- Elevated levels of MMP-8, MMP-9, and other MMPs were found in pediatric ALI lung secretions compared to controls.
- High MMP-9:TIMP-1 ratios were observed in ALI patients, indicating potential MMP dysregulation.
- During prolonged ALI (>10 days intubation), MMP-9 activity decreased and shifted to a latent form, while MMP-8 remained active.
Conclusions:
- A distinct set of MMP isoforms characterizes lung secretions in pediatric ALI.
- MMP-9:TIMP-1 ratios serve as potential biomarkers for distinguishing prolonged ALI courses.
- Inverse changes in MMP-8 and MMP-9 activity correlate with protracted ALI progression.
